Krebs Biochemicals and Industries Limited — Important, 07-08-2025: Updates

Krebs Biochemicals & Industries Ltd faced fines from NSE and BSE for non-compliance concerning its Board composition. The company has since rectified this by appointing four new Independent Directors. Management explained a 33-day delay was due to challenges in identifying suitable replacements, as all previous independent directors retired concurrently. The Board is committed to bolstering its governance and ensuring prompt adherence to all regulatory norms going forward, a positive development for investor confidence.